Respiratory System Abnormalities
Conditions
Keywords
Respiratory hazards, pulmonary function, chest wall mobility, functional ability, Manual Diaphragmatic Release
Brief summary
This study intended to examine the effect of manual diaphragm release on pulmonary function, chest wall mobility, and functional ability in female occupational cleaners with respiratory hazards.
Detailed description
Cleaning chores have been linked to exposure to various chemical agents that have the potential to cause harmful effects on both the respiratory system and cardiovascular markers, many cleaning products and disinfectants contain ingredients that can act as airway irritants. One of the physical therapy procedures that is used to manage chest disorders is manual diaphragm release which aims to lengthen the diaphragm musculature whereas encouraging better and more proficient contraction.
Interventions
The participant was supine, with his or her limbs relaxed. With the therapist's forearms aligned toward the participant's shoulders, the therapist gradually increased the depth of contact inside the costal margin during the subsequent respiratory cycles.
Respiratory re-training was given to participants in control group in form of slow and deep diaphragmatic breathing, exhalation through the nose with pursed lips (the participants were trained to emphasis on expiratory pressure against pursed lips), Breathing control and breathing-hold exercises, and Relaxation techniques:
Sponsors
Study design
Eligibility
Inclusion criteria
* Female occupational cleaners. * Age between 35 and 45. * Had work-related respiratory hazards. * Clinically stable. * No exacerbation in the previous 6 weeks. * Working in an occupation with respiratory hazards for at least 2 years. * Mild to moderate air way obstruction. * Willingness to participate in this study and provide a consent form.
Exclusion criteria
* Other cardiopulmonary diseases. * Body mass index \> 30 kg/ m2. * Previous thoracic or abdominal surgery. * Smokers and users of tobacco in any form (chewing, snuffing or water pipe). * Systemic conditions (e.g., diabetes mellitus, hypertension). * Sever airway obstructions. * Inability to perform the required exercises. * Inability to attend the scheduled sessions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum IgE | at first week | The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm. |
| Forced vital capacity | at first week | measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards |
| Forced expiratory volume in one second | at first week | measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards |
| pulmonary expiratory flow | at first week | measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Chest wall mobility | at first week | measured using tape measurement with maximum inspiration and expiration and the difference between them has been recorded in (cm). |
| Functional performance | at first week | Assessed using the 6-minute walk test |
Countries
Saudi Arabia